CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes andphenytoin adverse reactions correlation by Carlos Alexandre Twardowschy, Lineu César Werneck, Rosana Herminia Scola, Luciano De Paola, Carlos Eduardo Silvado

Subjects: “…CYP2C9…”
Get full text

FREQUENCIES OF POLYMORPHISMS IN THE CYTOCHROME’S P450 GENES OF WARFARIN TRANSFORMATION IN A EUROPEAN POPULATION OF EASTERN SIBERIA by T. A. Bairova, E. A. Novikova, F. I. Belyalov, E. A. Shchedreeva, K. D. Ievleva, O. V. Kalyuzhnaya, O. A. Ershova, V. G. Pustozerov, O. A. Kovaleva, I. V. Rasputina, I. A. Noskova, T. V. Batogova, O. V. Kuznetsova, O. Yu. Bogoslova, S. I. Kolesnikov

Subjects: “…cyp2c9…”
Get full text

Establishment of Acenocoumarol Pharmacogenetic Algorithm Including CYP2C9 and VKORC1 Genotypes in Bulgarian Patients Treated with Coumarin Anticoagulants by Tzveova R., Saraeva R., Dimitrova-Karamfilova A., Nachev G., Mitev V., Kaneva R., Pendicheva-Duhlenska D.

Subjects: Get full text

Effect of CYP2C9 on the migration, invasion and proliferation of hepatocellular carcinoma cells by ZHANG Tuo, LI Dajun, WANG Haitao, ZHANG Peng

Subjects: “…cyp2c9…”
Get full text

Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms by Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev

Subjects: Get full text

Mathematical modeling of pharmacokinetics and pharmacodynamics of losartan in relation to CYP2C9 allele variants by Dmitry Babaev, Elena Kutumova, Elena Kutumova, Fedor Kolpakov, Fedor Kolpakov

Subjects: Get full text

CYP2C9 Polymorphism is not Associated with Elevated Carcinoembryonic Antigen Levels by Claire Hall, Rebecca Roberts, Tony R. Merriman, Atanu Pal, Tim Eglinton, Chris Wakeman, Frank Frizelle

Subjects: Get full text

Pharmacogenetics: Influence of CYP2C9*2 and *3 alleles polymorphisms on Iraqi type 2 diabetic patients by Ghada S. Rasool, Asmaa A. Hussien, Suhad R. Al-Tayie, Salwa J. Al-Awadi, Hussein OM Al-Dahmoshi

Subjects: “…cyp2c9…”
Get full text

Laying the groundwork: Exploring pesticide exposure and genetic factors in south-eastern Brazilian farmers by Débora Dummer Meira, Victor Nogueira Da Gama Kohls, Matheus Correia Casotti, Luana Santos Louro, Gabriel Mendonça Santana, Thomas Erik Santos Louro, Adriana Madeira Alvares da Silva, Lorena Souza Castro Altoé, Raquel Reis Trabach, Sonia Groisman, Elizeu Fagundes de Carvalho, Jamila Alessandra Perini Machado, Stephanie Seneff, Iúri Drumond Louro

Subjects: “…CYP2C9…”
Get full text

Frequencies of CYP2C9 polymorphisms in a Syrian cohort by Weam Aldiban, Majd N. Aljamali, Lama A. Youssef

Subjects: “…CYP2C9…”
Get full text

DISTRIBUTION OF POLYMORPHISMS OF GENES OF STATINS METABOLISM AND TRANSPORT IN THE LIVER IN PATIENTS WITH CORONARY ARTERY DISEASE ETHNIC UZBEKS WITH SIMVASTATIN INTOLERANCE by A. B. Shek, R. D. Kurbanov, G. J. Abdullayeva, A. V. Nagai, A. A. Abdullaev, S. S. Ahmedova, S. U. Hoshimov, A. V. Ziyaeva

Subjects: “…cyp2c9…”
Get full text

The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients by Salha Jokhab, Maha M. AlRasheed, Dana Bakheet, Abdulkareem AlMomen, Nouf AlAboud, Farhad Kamali

Subjects: Get full text

VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY by D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes

Subjects: Get full text

CYP2C9 Polymorphism Study in Patients with Acute Back Pain and its Impact on the Effectiveness of Treatment with the Non-Steroidal Anti-Inflammatory Drugs by Maslova I., Mykhailovska N., Slobodin T.

Subjects: Get full text

Pharmacogenetics as a Way for Personalizing Diuretic Therapy: Focus on Torasemide by N. M. Gafurova, E. V. Shikh, O. D. Ostroumova

Subjects: Get full text

NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION by Ju. P. Skirdenko, N. A. Nikolayev

Subjects: Get full text

Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9 by O. G. Gribakina, G. B. Kolyvanov, A. A. Litvin, A. O. Viglinskaya, V. P. Zherdev

Subjects: Get full text

Clinical pharmacogenetics of angiotensin II receptor blockers: new perspectives of pharmacotherapy individualization by D. A. Sychev, G. S. Anikin, V. G. Belolipetskaya, I. B. Ignatyev, V. G. Kukes

Subjects: Get full text

Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms by O. G. Gribakina, R. V. Shevchenko, P. O. Bochkov, A. A. Novitskiy, A. A. Litvin, G. B. Kolyvanov, V. P. Zherdev

Subjects: Get full text

Exploring the Pharmacogenetic Landscape: Identification of Clinically Relevant Genotypes by a Nation-Wide Medical Testing Laboratory in Romania by Cristina Pop, Antoanela Curici, Oliviu Voștinaru, Anamaria Apan, Andra Piciu, Cristina Alina Silaghi, Horatiu Silaghi, Stefan Lucian Popa, Florica Ramona Dorobanțu, Cristina Mogoșan

Subjects: Get full text